HealthQuill Articles by: HealthQuill
Merck & Co., Inc., and Gilead Sciences, Inc.’s investigational combinational drug for HIV treatment, put on clinical hold last year, has met a secondary goal of a ‘high’ viral suppression rate in adults.
Drugs Health Pharma

Gilead, Merck’s HIV experimental drug scores ‘high’ on viral suppression

Merck & Co., Inc., and Gilead Sciences, Inc.’s investigational combinational drug for HIV treatment, put on clinical hold last year, has met a

Read More
Drugs Medical Pharma

FDA approves AbbVie’s new drug for advanced Parkinson’s disease

HQ Team October 19, 2024: The U.S. Food and Drug Administration (FDA) has approved AbbVei’s drug Vyalev for the treatment of advanced Parkinson’s

Read More
Walgreens Boots Alliance Inc., the second-largest pharmacy store chain in the US has bagged a $100 million gov­ern­ment fund­ing to ex­pand its clin­i­cal tri­al ca­pa­bil­i­ties, according to the company.
Drugs Medical Pharma

Treeline Biosciences discloses $421 million financing in latest filings

HQ Team October 19, 2024: Stealth startup Treeline Biosciences has raised another $421 million, one of the biggest raises of the year in

Read More
As the number of satellites skyrockets, scientists have called for a legally-binding global treaty to ensure the safety of Earth's orbit from space debris, which puts the planet and people at risk.
Climate Health Pharma

Spraying diamond dust in atmosphere can stem global warming: Study

HQ Team  October 18, 2024: As global greenhouse gas emissions continue to rise there is an urgency to find effective climate intervention solutions.

Read More
Sanofi and Orano Med agreed to form a new entity, valued at 1.9 billion euros ($2.06 billion), to develop radioligand medicines and the French company will invest 300 million euros for a 16% equity.
Drugs Health Pharma

Sanofi to invest $324m in entity with Orano Med for radioligand therapy

Sanofi and Orano Med agreed to form a new entity, valued at 1.9 billion euros ($2.06 billion), to develop radioligand medicines and the

Read More
china stocks up on emergency food supply
Climate Drugs Pharma

China boosts emergency food supply in response to climate events

HQ Team October 17, 2024: Extreme weather conditions and the increasing number of natural disaster events have forced China to take steps to

Read More
Lowering sodium intake can reduce blood pressure regardless of whether one is on medication, a study reveals.
Climate Health Medical

Hype and disputes surrounding blood pressure measurement

HQ Team October 17, 2024: Blood pressure measurement is a critical procedure in diagnosing and managing hypertension, yet it is fraught with scientific

Read More
Novavax, Inc.’s mid-stage trials on a combination of Covid-19 and influenza and a standalone influenza vaccine have been put on hold by the US regulator after a volunteer developed a serious nerve disorder.
Drugs Medical Pharma

USFDA puts on hold influenza, Covid-19 trial vaccines of Novavax

Novavax, Inc.’s mid-stage trials on a combination of Covid-19 and influenza and a standalone influenza vaccine have been put on hold by the

Read More
Climate Health Medical

Record decline in global carbon sinks in 2023; may upset climate models

HQ Team October 16, 2024: A new research  on the depleting carbon sinks on our planet has thrown up some crucial questions on

Read More
Twenty-four European universities have formed a network to impart skills to 10,000 medical students across undergraduate degree programmes to address current and future climate-related health threats, according to a  statement from the University of Glasgow.
Climate Health Pharma

European body to teach medical students health risks from climate change

Twenty-four European universities have formed a network to impart skills to 10,000 medical students across undergraduate degree programmes to address current and future

Read More